TCL Archive House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding July 2, 1993
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited September 10, 1976
TCL Archive Conte Institute Leafs Scientific Effort On Central Europe Environmental Clean-Up March 19, 1993
